The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1495
May 23, 2016
View Complete Issue         Table of Contents 2019 
Ciprofloxacin (Otiprio) for Tympanostomy Tube Insertion
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Ciprofloxacin (Otiprio) for Tympanostomy Tube Insertion
May 23, 2016 (Issue: 1495)
The FDA has approved ciprofloxacin 6% otic suspension (Otiprio – Otonomy) for single-dose prophylaxis in children with bilateral otitis media with effusion who are undergoing tympanostomy tube placement. It is the first drug to be approved for...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Ciprofloxacin (Otiprio) for Tympanostomy Tube Insertion
Article code: 1495c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.